Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mauricio Velasco-Delgado"'
Autor:
Felix Chu, Michael Harbell, Amy Manning-Bog, Alexander Scholz, Ngan Nguyen, Norman Greenberg, William Robinson, Daniel Emerling, Tito Serafini, Wei Cao, Yvonne Leung, Nikhil Vad, Anne Ye, Daniel Santos, Cathrin Czupalla, John Vivian, Carlene Williams, Judevin Sapugay, Shaun Lippow, Chantia Carroll, Lance Kates, Benjamin Haugen, Gary Bolton, Mark Armanini, Iraz Aydin, Mark Whidden, Mauricio Velasco-Delgado, Erin Wechsler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d68b61ac36ac49e5b4d60c03de821131
Autor:
Norman M. Greenberg, Chantia Carroll, Daniel Emerling, Cathrin J. Czupalla, Iraz T Aydin, Felix Chu, Benjamin Haugen, Shaun M. Lippow, Alexander Scholz, Ngan Nguyen, Nikhil Vad, Yvonne Leung, William H. Robinson, Wei Cao, Lance Kates, Mark Whidden, Gary Bolton, Mark Armanini, Amy Manning-Bog, Tito Serafini, John Vivian, Judevin Lugar Sapugay, Anne Ye, Daniel Santos, Carlene Williams, Michael Harbell, Erin Wechsler, Mauricio Velasco-Delgado
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background We have previously demonstrated adaptive antibody responses targeting public tumor antigens in cancer patients. ATRC-101, a clinical stage, engineered version of an antibody identified in such a patient, displays robust single-agent activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd191823fb6bbafeb9f1632e89fabd6f
https://doaj.org/article/d68b61ac36ac49e5b4d60c03de821131
https://doaj.org/article/d68b61ac36ac49e5b4d60c03de821131
Autor:
Jeff DeFalco, Ish Dhawan, Carl Millward, Daniel Emerling, Felix Chu, Iraz T Aydin, Shaun M. Lippow, Jonathan Benjamin, Michael Harbell, Cathrin J. Czupalla, Gilson Baia, Mark Whidden, Anne Ye, Amy Manning-Bog, Mauricio Velasco-Delgado, Dai-Chen Wu, John Vivian, Norman M. Greenberg, Yvonne Leung, Tito Serafini, Alexander Scholz, Nikhil Vad, Judevin Lugar-Supagay, Ngan Nguyen, William H. Robinson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background We have previously described ATRC-101, a fully human, engineered IgG1 antibody binding a tumor-restricted ribonucleoprotein (RNP) complex as its target. ATRC-101 is currently under evaluation in the clinic as a monotherapy for solid tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b700070b6e5ac8019bf62cda9f6bb3
https://doaj.org/article/9a59eb33c2834ec5915b11e07f6a0c7d
https://doaj.org/article/9a59eb33c2834ec5915b11e07f6a0c7d
Autor:
James J. Kadiri, Martina Rami, Petteri Rinne, Salla Nuutinen, Maija Hollmén, Eriika Savontaus, Sabine Steffens, Mauricio Velasco-Delgado, Miro Viitala
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Supplemental Digital Content is available in the text.
Objective— The MC1-R (melanocortin 1 receptor) is expressed by monocytes and macrophages where it mediates anti-inflammatory actions. MC1-R also protects against macrophage foam cell forma
Objective— The MC1-R (melanocortin 1 receptor) is expressed by monocytes and macrophages where it mediates anti-inflammatory actions. MC1-R also protects against macrophage foam cell forma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::853d14dc4ac8d590100cddb93ec9cba4
https://doi.org/10.1161/atvbaha.117.310418
https://doi.org/10.1161/atvbaha.117.310418